SNORA72 Activates the Notch1/c-Myc Pathway to Promote Stemness Transformation of Ovarian Cancer Cells

Liwen Zhang1,2,3,4, Rong Ma1,2,3,4, Mengcong Gao1,2,3,4

  • 1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, China.

Insights

Small nucleolar RNA SNORA72 promotes ovarian cancer stem cell properties, enhancing self-renewal and migration. This occurs via the Notch1/c-Myc pathway, offering a potential therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Cancer stem cells (CSCs) drive tumor progression, metastasis, and recurrence.
  • Small nucleolar RNAs (snoRNAs) are implicated in various cancers, but their role in ovarian CSCs is largely unexplored.

Purpose of the Study:

  • To investigate the function of SNORA72 in regulating the stemness of ovarian cancer stem cells (OCSCs).
  • To elucidate the molecular mechanisms underlying SNORA72's effects on OCSCs.

Main Methods:

  • Serum-free culture of OVCAR-3 and CAOV-3 cells to induce OCSC characteristics.
  • Overexpression and silencing of SNORA72.
  • Assessment of self-renewal and migration abilities.
  • Analysis of stemness markers (Nanog, Oct4, CD133) and signaling pathway components (Notch1, c-Myc) via mRNA and protein expression.
  • Notch1 knockdown experiments.

Main Results:

  • SNORA72 was significantly upregulated in OCSCs.
  • SNORA72 overexpression enhanced OCSC self-renewal, migration, and stemness markers.
  • SNORA72 upregulated Notch1 and c-Myc expression.
  • SNORA72 silencing reversed these effects.
  • Notch1 knockdown counteracted the pro-stemness effects of SNORA72.

Conclusions:

  • SNORA72 activates ovarian cancer cell stemness through the Notch1/c-Myc pathway.
  • SNORA72 represents a novel therapeutic target for enhancing ovarian cancer treatment efficacy.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.3K
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.9K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K